AI in Clinical Trials Market by Function (Patient Recruitment, Site Optimization, Data Management, Quality, Regulatory), Phase (I, II, III), Indication (Cancer, CNS, CVS), Tool, End-User (Pharma/Biotech, CRO, Hospitals) & Region - Global Forecast to 2030

AI in Clinical Trials Market by Function (Patient Recruitment, Site Optimization, Data Management, Quality, Regulatory), Phase (I, II, III), Indication (Cancer, CNS, CVS), Tool, End-User (Pharma/Biotech, CRO, Hospitals) & Region - Global Forecast to 2030

The AI in clinical trials market is projected to reach USD 2.74 billion by 2030 from USD 1.35 billion in 2024, at a CAGR of 12.4% from 2024 to 2030. The growing demand for improvements in effectiveness, recruitment of patients in a shorter duration, and accurate analysis of data is the key factor fuelling the market for AI in clinical trials. Solutions powered by AI assist in shortening the duration of various phases of the trial and also in improving patient retention levels using predictive modelling and engagement strategies. In addition, the increase in use of wearables and EMR systems facilitates monitoring at every stage of the course, hence reinforcing the application of AI in trials. Nevertheless, a few obstacles including regulatory norms, prohibitively high cost of implementation and fears of data breach act as constraints hindering the full-scale use of AI in clinical trials.

“Infectious diseases had the fastest growth rate in the AI in clinical trials market during the forecast period, by indication.”

In the sector of conducting clinical studies with the application of AI technologies, it is likely that among all indications infectious diseases will experience the most rapid growth. Such development is very fast owing to the global appeal for quicker and better solutions against disease outbreaks such as the pandemic. AI speed up the patient enrolment process, enhance forecasting, better structure the trials all of which help to deal with fast spreading viruses in a common sense. There has been a significant rise in the use of advanced technologies especially AI owing to the increased campaigns of fighting infectious diseases.

“By end user, the pharmaceutical & biopharma companies to account for largest market share in 2023.”

By end user, AI in clinical trials market is bifurcated into pharmaceutical & biopharma companies, research institutes & labs, healthcare providers, contract research organizations, and medical device manufacturers. The majority of the market share to be occupied by pharmaceutical & biopharma companies’ segment. This is due to the great extent of research and development expenditure, which in turn raises the application of AI for faster drug development processes, better clinical trial designs as well as enhanced patient recruitment for the companies. Such AI systems are designed for such firms to help in a complex analysis of large data sets, quicken the introduction of products into the market, and control the ever-increasing costs which are very essential in winning the competition in the case of the pharmaceutical sector.

“Asia Pacific is estimated to register the highest CAGR over the forecast period.”

The AI in clinical trials market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific AI in clinical trials market is projected to register highest CAGR during the forecast period. The Asia Pacific is benefiting from the fast-developing healthcare infrastructure, advances in AI technologies and expansion of clinical research. With countries such as China, India and Japan encouraging the use of AI in healthcare to facilitate large and varied populations and organize clinical trials more efficiently. Furthermore, owing to the favourable government policies, increasing proliferations of contract research organizations (CROs) and cheaper operation costs in the market relative to the Western regions, many multinational pharmaceutical companies are making it their business to invest in AI clinical trials within the region.

Breakdown of supply-side primary interviews by company type, designation, and region:

By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)

By Designation: Managers (40%), Directors (35%), and Others (25%)

By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%) and Middle East Africa (5%)

List of Companies Profiled in the Report:

IQVIA Inc. (US)

Saama. (US)

Dassault Systèmes (Medidata) (France)

Phesi (US)

PathAI, Inc. (US)

Unlearn.ai, Inc. (US)

Deep6.ai (US)

Microsoft (US)

IBM (US)

NVIDIA Corporation (US)

Insilico Medicine (US)

ConcertAI. (US)

AiCure. (US)

Median Technologies. (France)

Lantern Pharma Inc. (US)

Citeline, a Norstella Company (US)

Tempus AI, Inc. (US)

TriNetX, LLC (US)

ReviveMed Inc. (US)

Euretos. (US)

VeriSIM Life. (US)

Triomics (US)

Ardigen (Poland)

QuantHealth Ltd. US)

DEEP GENOMICS. (Canada)

Research Coverage:

This research report categorizes the AI in clinical trials market by offerings (end-to-end solutions, niche solutions, technology providers and services), function (patient recruitment, trial design optimization, data management & quality control, adverse event prediction & detection, drug repurposing, and regulatory compliance), phase (phase I, phase II, phase III and phase IV), deployment mode (cloud-based solutions, and on-premise solutions), indication (oncology, neurological diseases, cardiovascular diseases, metabolic diseases, infectious diseases, immunology diseases, and others (gastrointestinal, respiratory & reproductive), technology (machine learning, NLP, computer vision, robotic process automation, and others), application (biomarkers, cell & gene therapy, regenerative medicine, and medical devices & diagnostics), end user (pharmaceutical & biotechnology companies, research institutes & labs, healthcare providers, contract research organizations (CROs), and medical device manufacturers) and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the AI in clinical trials market. A thorough analysis of the key industry players has been done to provide insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the AI in clinical trials market. Competitive analysis of upcoming startups in the AI in clinical trials market ecosystem is covered in this report.

Reasons to Buy the Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall AI in clinical trials market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers: (Growing demand for faster and more efficient drug development), restraints (High costs associated with implementing AI solutions), opportunities (Increased focus on precision medicine), and challenges (Complexity of integrating AI into traditional clinical trial frameworks) influencing the growth of the AI in clinical trials market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the AI in clinical trials market.

Market Development: Comprehensive information about lucrative markets – the report analyses the AI in clinical trials market across varied regions.

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the AI in clinical trials market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as IQVIA Inc. (US), Dassault Systèmes (Medidata) (France), Tempus AI, Inc. (US), Insilico Medicine (US), ConcertAI. (US), AiCure. (US) PathAI, Inc. (US), etc. among others in AI in clinical trials market

AI in Clinical Trials Market by Function (Patient Recruitment, Site Optimization, Data Management, Quality, Regulatory), Phase (I, II, III), Indication (Cancer, CNS, CVS), Tool, End-User (Pharma/Biotech, CRO, Hospitals) & Region - Global Forecast to 2030

Tables List

Table 1 Ai In Clinical Trials Market: Inclusions & Exclusions

Table 2 Ai In Clinical Trials Market: Study Assumptions

Table 3 Ai In Clinical Trials Market: Risk Assessment

Table 4 Ai In Clinical Trials Market: Impact Analysis

Table 5 Case Study 1: Ai-powered Approach To Overcome Challenges In

Ipf Drug Development

Table 6 Case Study 2: Revolutionizing Clinical Trial Enrollment With

Advanced Matching Networks

Table 7 Case Study 3: Breakthrough In Cancer Treatment With Fda Approval For Phase 1 Trials

Table 8 Ai In Clinical Trials Market: Porter’s Five Forces

Table 9 Influence Of Stakeholders On Buying Process For Top Three

End Users (%)

Table 10 Key Buying Criteria For Top Three End Users

Table 11 List Of Regulatory Bodies, Government Agencies,

And Other Organizations

Table 12 North America: Regulatory Framework

Table 13 Europe: Regulatory Framework

Table 14 Asia Pacific: Regulatory Framework

Table 15 Middle East & Africa: Regulatory Framework

Table 16 Latin America: Regulatory Framework

Table 17 Ai In Clinical Trials Market: List Of Patents/Patent

Applications, 2023–2024

Table 18 Indicative Price Of Key Ai Software, By Key Player, 2023

Table 19 Indicative Price Trend Of Key Ai Software, By Region, 2022–2024

Table 20 Ai In Clinical Trials Market: Key Conferences & Events,

January 2024–december 2025

Table 21 Ai In Clinical Trials Market: Unmet Needs

Table 22 Ai In Clinical Trials Market: End-user Expectations

Table 23 Ai In Clinical Trials Market, By Offering, 2022–2030 (Usd Million)

Table 24 Ai In Clinical Trials Market For End-to-end Solutions,

By Country, 2022–2030 (Usd Million)

Table 25 Ai In Clinical Trials Market For Niche Solutions, By Country,

2022–2030 (Usd Million)

Table 26 Ai In Clinical Trials Market For Technology Providers, By Country, 2022–2030 (Usd Million)

Table 27 Ai In Clinical Trials Market For Services, By Country,

2022–2030 (Usd Million)

Table 28 Consulting Services Market, By Country, 2022–2030 (Usd Million)

Table 29 Implementation Services & Outgoing It Support Market,

By Country, 2022–2030 (Usd Million)

Table 30 Training & Education Services Market, By Country,

2022–2030 (Usd Million)

Table 31 Post-sales & Maintenance Services Market, By Country,

2022–2030 (Usd Million)

Table 32 Ai In Clinical Trials Market, By Function, 2022–2030 (Usd Million)

Table 33 Ai In Clinical Trials Market For Patient Recruitment, By Type,

2022–2030 (Usd Million)

Table 34 Ai In Clinical Trials Market For Patient Recruitment, By Country,

2022–2030 (Usd Million)

Table 35 Patient Identification & Screening Market, By Country,

2022–2030 (Usd Million)

Table 36 Patient Engagement & Retention Market, By Country,

2022–2030 (Usd Million)

Table 37 Site Optimization Market, By Country, 2022–2030 (Usd Million)

Table 38 Ai In Clinical Trials Market For Trial Design Optimization, By Type, 2022–2030 (Usd Million)

Table 39 Ai In Clinical Trials Market For Trial Design Optimization, By Country, 2022–2030 (Usd Million)

Table 40 Ai In Clinical Trials Market For Workflow Management, By Country, 2022–2030 (Usd Million)

Table 41 Ai In Clinical Trials Market For Predictive Modeling, By Country,

2022–2030 (Usd Million)

Table 42 Ai In Clinical Trials Market For Risk Management, By Country,

2022–2030 (Usd Million)

Table 43 Ai In Clinical Trials Market For Data Management & Quality Control,

By Country, 2022–2030 (Usd Million)

Table 44 Ai In Clinical Trials Market For Adverse Event Prediction & Detection, By Country, 2022–2030 (Usd Million)

Table 45 Ai In Clinical Trials Market For Drug Repurposing, By Country,

2022–2030 (Usd Million)

Table 46 Ai In Clinical Trials Market For Regulatory Compliance,

By Country, 2022–2030 (Usd Million)

Table 47 Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 48 Ai In Phase 1 Clinical Trials Market, By Country,

2022–2030 (Usd Million)

Table 49 Ai In Phase Ii Clinical Trials Market, By Country,

2022–2030 (Usd Million)

Table 50 Ai In Phase Iii Clinical Trials Market, By Country,

2022–2030 (Usd Million)

Table 51 Ai In Phase Iv Clinical Trials Market, By Country,

2022–2030 (Usd Million)

Table 52 Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 53 Ai In Clinical Trials Market For Cloud-based Solutions,

By Type, 2022–2030 (Usd Million)

Table 54 Ai In Clinical Trials Market For Cloud-based Solutions,

By Country, 2022–2030 (Usd Million)

Table 55 Public Cloud-based Solutions Market, By Country,

2022–2030 (Usd Million)

Table 56 Private Cloud-based Solutions Market, By Country,

2022–2030 (Usd Million)

Table 57 Multi Cloud-based Solutions Market, By Country,

2022–2030 (Usd Million)

Table 58 Hybrid Cloud-based Solutions Market, By Country,

2022–2030 (Usd Million)

Table 59 Ai In Clinical Trials Market For On-premises Solutions, By Country, 2022–2030 (Usd Million)

Table 60 Ai In Clinical Trials Market, By Indication, 2022–2030 (Usd Million)

Table 61 Ai In Clinical Trials Market For Oncology, By Country,

2022–2030 (Usd Million)

Table 62 Ai In Clinical Trials Market For Neurological Diseases, By Country, 2022–2030 (Usd Million)

Table 63 Ai In Clinical Trials Market For Cardiovascular Diseases, By Country, 2022–2030 (Usd Million)

Table 64 Ai In Clinical Trials Market For Metabolic Diseases, By Country,

2022–2030 (Usd Million)

Table 65 Ai In Clinical Trials Market For Infectious Diseases, By Country,

2022–2030 (Usd Million)

Table 66 Ai In Clinical Trials Market For Immunology Diseases, By Country, 2022–2030 (Usd Million)

Table 67 Ai In Clinical Trials Market For Other Diseases, By Country,

2022–2030 (Usd Million)

Table 68 Ai In Clinical Trials Market, By Technology, 2022–2030 (Usd Million)

Table 69 Ai In Clinical Trials Market For Machine Learning, By Type,

2022–2030 (Usd Million)

Table 70 Ai In Clinical Trials Market For Machine Learning, By Country,

2022–2030 (Usd Million)

Table 71 Deep Learning Market, By Country, 2022–2030 (Usd Million)

Table 72 Supervised Learning Market, By Country, 2022–2030 (Usd Million)

Table 73 Unsupervised Learning Market, By Country, 2022–2030 (Usd Million)

Table 74 Reinforcement Learning Market, By Country, 2022–2030 (Usd Million)

Table 75 Other Machine Learning Technologies Market, By Country,

2022–2030 (Usd Million)

Table 76 Ai In Clinical Trials Market For Natural Language Processing,

By Country, 2022–2030 (Usd Million)

Table 77 Ai In Clinical Trials Market For Computer Vision, By Country,

2022–2030 (Usd Million)

Table 78 Ai In Clinical Trials Market For Robotic Process Automation,

By Country, 2022–2030 (Usd Million)

Table 79 Ai In Clinical Trials Market For Other Technologies, By Country,

2022–2030 (Usd Million)

Table 80 Ai In Clinical Trials Market, By Application, 2022–2030 (Usd Million)

Table 81 Ai In Clinical Trials Market For Biomarkers, By Country,

2022–2030 (Usd Million)

Table 82 Ai In Clinical Trials Market For Cell & Gene Therapy, By Country,

2022–2030 (Usd Million)

Table 83 Ai In Clinical Trials Market For Regenerative Medicines,

By Country, 2022–2030 (Usd Million)

Table 84 Ai In Clinical Trials Market For Medical Devices & Diagnostics,

By Country, 2022–2030 (Usd Million)

Table 85 Ai In Clinical Trials Market, By End User, 2022–2030 (Usd Million)

Table 86 Ai In Clinical Trials Market For Pharmaceutical & Biopharmaceutical Companies, By Country, 2022–2030 (Usd Million)

Table 87 Ai In Clinical Trials Market For Research Institutes & Laboratories,

By Country, 2022–2030 (Usd Million)

Table 88 Ai In Clinical Trials Market For Healthcare Providers,

By Country, 2022–2030 (Usd Million)

Table 89 Recent Acquisitions /Collaborations With Contract Research Organizations

Table 90 Ai In Clinical Trials Market For Contract Research Organizations,

By Country, 2022–2030 (Usd Million)

Table 91 Ai In Clinical Trials Market For Medical Device Manufacturers,

By Country, 2022–2030 (Usd Million)

Table 92 Ai In Clinical Trials Market, By Region, 2022–2030 (Usd Million)

Table 93 North America: Ai In Clinical Trials Market, By Country,

2022–2030 (Usd Million)

Table 94 North America: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 95 North America: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 96 North America: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 97 North America: Ai In Clinical Trials Market, By Phase,

2022–2030 (Usd Million)

Table 98 North America: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 99 North America: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 100 North America: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 101 North America: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 102 Us: Indicative List Of Strategic Developments

Table 103 Us: Ai In Clinical Trials Market, By Offering, 2022–2030 (Usd Million)

Table 104 Us: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 105 Us: Ai In Clinical Trials Market, By Indication, 2022–2030 (Usd Million)

Table 106 Us: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 107 Us: Ai In Clinical Trials Market, By Application, 2022–2030 (Usd Million)

Table 108 Us: Ai In Clinical Trials Market, By Technology, 2022–2030 (Usd Million)

Table 109 Us: Ai In Clinical Trials Market, By Function, 2022–2030 (Usd Million)

Table 110 Us: Ai In Clinical Trials Market, By End User, 2022–2030 (Usd Million)

Table 111 Canada: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 112 Canada: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 113 Canada: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 114 Canada: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 115 Canada: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 116 Canada: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 117 Canada: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 118 Canada: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 119 Europe: Ai In Clinical Trials Market, By Country,

2022–2030 (Usd Million)

Table 120 Europe: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 121 Europe: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 122 Europe: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 123 Europe: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 124 Europe: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 125 Europe: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 126 Europe: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 127 Europe: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 128 Uk: Ai In Clinical Trials Market, By Offering, 2022–2030 (Usd Million)

Table 129 Uk: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 130 Uk: Ai In Clinical Trials Market, By Indication, 2022–2030 (Usd Million)

Table 131 Uk: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 132 Uk: Ai In Clinical Trials Market, By Application, 2022–2030 (Usd Million)

Table 133 Uk: Ai In Clinical Trials Market, By Technology, 2022–2030 (Usd Million)

Table 134 Uk: Ai In Clinical Trials Market, By Function, 2022–2030 (Usd Million)

Table 135 Uk: Ai In Clinical Trials Market, By End User, 2022–2030 (Usd Million)

Table 136 Germany: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 137 Germany: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 138 Germany: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 139 Germany: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 140 Germany: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 141 Germany: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 142 Germany: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 143 Germany: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 144 France: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 145 France: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 146 France: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 147 France: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 148 France: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 149 France: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 150 France: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 151 France: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 152 Italy: Ai In Clinical Trials Market, By Offering, 2022–2030 (Usd Million)

Table 153 Italy: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 154 Italy: Ai In Clinical Trials Market, By Indication, 2022–2030 (Usd Million)

Table 155 Italy: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 156 Italy: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 157 Italy: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 158 Italy: Ai In Clinical Trials Market, By Function, 2022–2030 (Usd Million)

Table 159 Italy: Ai In Clinical Trials Market, By End User, 2022–2030 (Usd Million)

Table 160 Spain: Ai In Clinical Trials Market, By Offering, 2022–2030 (Usd Million)

Table 161 Spain: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 162 Spain: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 163 Spain: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 164 Spain: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 165 Spain: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 166 Spain: Ai In Clinical Trials Market, By Function, 2022–2030 (Usd Million)

Table 167 Spain: Ai In Clinical Trials Market, By End User, 2022–2030 (Usd Million)

Table 168 Rest Of Europe: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 169 Rest Of Europe: Ai In Clinical Trials Market, By Deployment Mode, 2022–2030 (Usd Million)

Table 170 Rest Of Europe: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 171 Rest Of Europe: Ai In Clinical Trials Market, By Phase,

2022–2030 (Usd Million)

Table 172 Rest Of Europe: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 173 Rest Of Europe: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 174 Rest Of Europe: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 175 Rest Of Europe: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 176 Asia Pacific: Ai In Clinical Trials Market, By Country,

2022–2030 (Usd Million)

Table 177 Asia Pacific: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 178 Asia Pacific: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 179 Asia Pacific: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 180 Asia Pacific: Ai In Clinical Trials Market, By Phase,

2022–2030 (Usd Million)

Table 181 Asia Pacific: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 182 Asia Pacific: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 183 Asia Pacific: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 184 Asia Pacific: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 185 Japan: Ai In Clinical Trials Market, By Offering, 2022–2030 (Usd Million)

Table 186 Japan: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 187 Japan: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 188 Japan: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 189 Japan: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 190 Japan: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 191 Japan: Ai In Clinical Trials Market, By Function, 2022–2030 (Usd Million)

Table 192 Japan: Ai In Clinical Trials Market, By End User, 2022–2030 (Usd Million)

Table 193 China: Ai In Clinical Trials Market, By Offering, 2022–2030 (Usd Million)

Table 194 China: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 195 China: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 196 China: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 197 China: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 198 China: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 199 China: Ai In Clinical Trials Market, By Function, 2022–2030 (Usd Million)

Table 200 China: Ai In Clinical Trials Market, By End User, 2022–2030 (Usd Million)

Table 201 India: Ai In Clinical Trials Market, By Offering, 2022–2030 (Usd Million)

Table 202 India: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 203 India: Ai In Clinical Trials Market, By Indication, 2022–2030 (Usd Million)

Table 204 India: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 205 India: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 206 India: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 207 India: Ai In Clinical Trials Market, By Function, 2022–2030 (Usd Million)

Table 208 India: Ai In Clinical Trials Market, By End User, 2022–2030 (Usd Million)

Table 209 Rest Of Asia Pacific: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 210 Rest Of Asia Pacific: Ai In Clinical Trials Market, By Deployment Mode, 2022–2030 (Usd Million)

Table 211 Rest Of Asia Pacific: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 212 Rest Of Asia Pacific: Ai In Clinical Trials Market, By Phase,

2022–2030 (Usd Million)

Table 213 Rest Of Asia Pacific: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 214 Rest Of Asia Pacific: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 215 Rest Of Asia Pacific: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 216 Rest Of Asia Pacific: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 217 Latin America: Ai In Clinical Trials Market, By Country,

2022–2030 (Usd Million)

Table 218 Latin America: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 219 Latin America: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 220 Latin America: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 221 Latin America: Ai In Clinical Trials Market, By Phase,

2022–2030 (Usd Million)

Table 222 Latin America: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 223 Latin America: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 224 Latin America: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 225 Latin America: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 226 Brazil: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 227 Brazil: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 228 Brazil: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 229 Brazil: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 230 Brazil: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 231 Brazil: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 232 Brazil: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 233 Brazil: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 234 Mexico: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 235 Mexico: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 236 Mexico: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 237 Mexico: Ai In Clinical Trials Market, By Phase, 2022–2030 (Usd Million)

Table 238 Mexico: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 239 Mexico: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 240 Mexico: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 241 Mexico: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 242 Rest Of Latin America: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 243 Rest Of Latin America: Ai In Clinical Trials Market, By Deployment Mode, 2022–2030 (Usd Million)

Table 244 Rest Of Latin America: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 245 Rest Of Latin America: Ai In Clinical Trials Market, By Phase,

2022–2030 (Usd Million)

Table 246 Rest Of Latin America: Ai In Clinical Trials Market, By Application, 2022–2030 (Usd Million)

Table 247 Rest Of Latin America: Ai In Clinical Trials Market, By Technology, 2022–2030 (Usd Million)

Table 248 Rest Of Latin America: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 249 Rest Of Latin America: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 250 Middle East & Africa: Ai In Clinical Trials Market, By Region,

2022–2030 (Usd Million)

Table 251 Middle East & Africa: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 252 Middle East & Africa: Ai In Clinical Trials Market, By Deployment Mode, 2022–2030 (Usd Million)

Table 253 Middle East & Africa: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 254 Middle East & Africa: Ai In Clinical Trials Market, By Phase,

2022–2030 (Usd Million)

Table 255 Middle East & Africa: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 256 Middle East & Africa: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 257 Middle East & Africa: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 258 Middle East & Africa: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 259 Gcc Countries: Ai In Clinical Trials Market, By Offering,

2022–2030 (Usd Million)

Table 260 Gcc Countries: Ai In Clinical Trials Market, By Deployment Mode,

2022–2030 (Usd Million)

Table 261 Gcc Countries: Ai In Clinical Trials Market, By Indication,

2022–2030 (Usd Million)

Table 262 Gcc Countries: Ai In Clinical Trials Market, By Phase,

2022–2030 (Usd Million)

Table 263 Gcc Countries: Ai In Clinical Trials Market, By Application,

2022–2030 (Usd Million)

Table 264 Gcc Countries: Ai In Clinical Trials Market, By Technology,

2022–2030 (Usd Million)

Table 265 Gcc Countries: Ai In Clinical Trials Market, By Function,

2022–2030 (Usd Million)

Table 266 Gcc Countries: Ai In Clinical Trials Market, By End User,

2022–2030 (Usd Million)

Table 267 Rest Of Middle East & Africa: Ai In Clinical Trials Market,

By Offering, 2022–2030 (Usd Million)

Table 268 Rest Of Middle East & Africa: Ai In Clinical Trials Market,

By Deployment Mode, 2022–2030 (Usd Million)

Table 269 Rest Of Middle East & Africa: Ai In Clinical Trials Market,

By Indication, 2022–2030 (Usd Million)

Table 270 Rest Of Middle East & Africa: Ai In Clinical Trials Market,

By Phase, 2022–2030 (Usd Million)

Table 271 Rest Of Middle East & Africa: Ai In Clinical Trials Market,

By Application, 2022–2030 (Usd Million)

Table 272 Rest Of Middle East & Africa: Ai In Clinical Trials Market,

By Technology, 2022–2030 (Usd Million)

Table 273 Rest Of Middle East & Africa: Ai In Clinical Trials Market, By Function, 2022–2030 (Usd Million)

Table 274 Rest Of Middle East & Africa: Ai In Clinical Trials Market, By End User, 2022–2030 (Usd Million)

Table 275 Overview Of Strategies Deployed By Key Players In Ai In Clinical

Trials Market

Table 276 Ai In Clinical Trials Market: Degree Of Competition

Table 277 Ai In Clinical Trials Market: Region Footprint

Table 278 Ai In Clinical Trials Market: Offering Footprint

Table 279 Ai In Clinical Trials Market: Function Footprint

Table 280 Ai In Clinical Trials Market: End-user Footprint

Table 281 Ai In Clinical Trials Market: Detailed List Of Key Startups/Smes

Table 282 Ai In Clinical Trials Market: Competitive Benchmarking Of Key Emerging Players/Startups

Table 283 Ai In Clinical Trials Market: Product/Service/Solution Launches, January 2021–november 2024

Table 284 Ai In Clinical Trials Market: Deals, January 2021– November 2024

Table 285 Ai In Clinical Trials Market: Other Developments,

January 2021– November 2024

Table 286 Iqvia Inc.: Company Overview

Table 287 Iqvia Inc.: Products/Services/Solutions Offered

Table 288 Iqvia Inc.: Solution Launches, January 2021–november 2024

Table 289 Iqvia Inc.: Deals, January 2021–november 2024

Table 290 Dassault Systèmes (Medidata): Company Overview

Table 291 Dassault Systèmes (Medidata): Products/Services/Solutions Offered

Table 292 Dassault Systèmes (Medidata): Solution Launches,

January 2021– November 2024

Table 293 Dassault Systèmes (Medidata): Deals, January 2021–november 2024

Table 294 Insilico Medicine: Company Overview

Table 295 Insilico Medicine: Products/Services/Solutions Offered

Table 296 Insilico Medicine: Other Developments, January 2021–november 2024

Table 297 Tempus Ai, Inc.: Company Overview

Table 298 Tempus Ai, Inc.: Products/Services/Solutions Offered

Table 299 Tempus Ai, Inc.: Solution Launches, January 2021–november 2024

Table 300 Tempus Ai, Inc.: Deals, January 2021–november 2024

Table 301 Tempus Ai, Inc.: Other Developments, January 2021–november 2024

Table 302 Nvidia Corporation: Company Overview

Table 303 Nvidia Corporation: Products/Services/Solutions Offered

Table 304 Nvidia Corporation: Product And Service Launches, January 2021– November 2024

Table 305 Nvidia Corporation: Deals, January 2021–november 2024

Table 306 Saama: Company Overview

Table 307 Saama: Products/Services/Solutions Offered

Table 308 Saama: Solution Launches, January 2021−november 2024

Table 309 Saama.: Deals, January 2021−november 2024

Table 310 Phesi: Company Overview

Table 311 Phesi: Products/Services/Solutions Offered

Table 312 Phesi: Solution Launches, January 2021−november 2024

Table 313 Phesi: Deals, January 2021–november 2024

Table 314 Pathai, Inc.: Company Overview

Table 315 Pathai, Inc.: Products/Services/Solutions Offered

Table 316 Unlearn.Ai, Inc.: Company Overview

Table 317 Unlearn.Ai, Inc.: Products/Services/Solutions Offered

Table 318 Unlearn.Ai, Inc.: Solution Launches, January 2021−november 2024

Table 319 Unlearn.Ai, Inc.: Deals, January 2021−november 2024

Table 320 Unlearn.Ai, Inc.: Other Developments, January 2021–november 2024

Table 321 Deep6.Ai: Company Overview

Table 322 Deep6.Ai: Products/Services/Solutions Offered

Table 323 Deep6.Ai: Solution Launch, January 2021−november 2024

Table 324 Deep6.Ai: Deals, January 2021−november 2024

Table 325 Microsoft: Company Overview

Table 326 Microsoft: Products/Services/Solutions Offered

Table 327 Microsoft Corporation: Deals, January 2021–november 2024

Table 328 Ibm: Company Overview

Table 329 Ibm: Products/Services/Solutions Offered

Table 330 Ibm: Deals, January 2021–november 2024

Table 331 Concertai: Company Overview

Table 332 Concertai: Products/Services/Solutions Offered

Table 333 Concertai: Solution Launches, January 2021−november 2024

Table 334 Concertai: Deals, January 2021− November 2024

Table 335 Concertai: Other Developments, January 2021− November 2024

Table 336 Aicure: Company Overview

Table 337 Aicure: Products/Services/Solutions Offered

Table 338 Aicure: Service Launches, January 2021−november 2024

Table 339 Aicure: Deals, January 2021–november 2024

Table 340 Median Technologies: Company Overview

Table 341 Median Technologies: Products/Services/Solutions Offered

Table 342 Lantern Pharma Inc.: Company Overview

Table 343 La ntern Pharma Inc.: Products/Services/Solutions Offered

Table 344 Lantern Pharma Inc.: Deals, January 2021−november 2024

Table 345 Citeline, A Norstella Company: Company Overview

Table 346 Citeline, A Norstella Company: Products/Services/Solutions Offered

Table 347 Citeline, A Norstella Company: Solution Launches, January 2021− November 2024

Table 348 Citeline, A Norstella Company: Deals, January 2021–november 2024

Table 349 Trinetx, Llc: Company Overview

Table 350 Trinetx, Llc: Products/Services/Solutions Offered

Table 351 Trinetx, Llc: Deals, January 2021−november 2024

Table 352 Revivemed Inc.: Company Overview

Table 353 Euretos: Company Overview

Table 354 Verisim Life: Company Overview

Table 355 Triomics: Company Overview

Table 356 Ardigen: Company Overview

Table 357 Quanthealth Ltd.: Company Overview

Table 358 Deep Genomics: Company Overview

Figures List

Figure 1 Ai In Clinical Trials Market: Segments Considered

Figure 2 Ai In Clinical Trials Market: Years Considered

Figure 3 Ai In Clinical Trials Market: Research Design

Figure 4 Ai In Clinical Trials Market: Key Data From Secondary Sources

Figure 5 Ai In Clinical Trials Market: Key Primary Sources

Figure 6 Ai In Clinical Trials Market: Key Data From Primary Sources

Figure 7 Ai In Clinical Trials Market: Key Insights From Primaries

Figure 8 Breakdown Of Primary Interviews (Demand Side): By Company Type, Designation, And Region

Figure 9 Market Size Estimation: Supply-side Revenue Share Analysis

Figure 10 Ai In Clinical Trials Market: Top-down Approach

Figure 11 Ai In Clinical Trials Market: Cagr Projections From Analysis Of

Drivers, Restraints, Opportunities, And Challenges

Figure 12 Cagr Projections: Supply-side Analysis

Figure 13 Ai In Clinical Trials Market: Data Triangulation

Figure 14 Ai In Clinical Trials Market, By Offering, 2024 Vs. 2030 (Usd Million)

Figure 15 Ai In Clinical Trials Market, By Function, 2024 Vs. 2030 (Usd Million)

Figure 16 Ai In Clinical Trials Market, By Deployment Mode,

2024 Vs. 2030 (Usd Million)

Figure 17 Ai In Clinical Trials Market, By Phase, 2024 Vs. 2030 (Usd Million)

Figure 18 Ai In Clinical Trials Market, By Application, 2024 Vs. 2030 (Usd Million)

Figure 19 Ai In Clinical Trials Market, By Technology, 2024 Vs. 2030 (Usd Million)

Figure 20 Ai In Clinical Trials Market, By Indication, 2024 Vs. 2030 (Usd Million)

Figure 21 Ai In Clinical Trials Market, By End User, 2024 Vs. 2030 (Usd Million)

Figure 22 Ai In Clinical Trials Market: Regional Snapshot

Figure 23 Need For Data Standardization And Favorable Government

Policies To Drive Market

Figure 24 North America To Dominate Ai In Clinical Trials Market During Forecast Period

Figure 25 Us And Pharmaceutical & Biopharmaceutical Companies Accounted For Largest Share Of North American Market In 2023

Figure 26 Uk To Register Highest Growth Rate During Study Period

Figure 27 Developed Markets To Register Higher Growth Rates

From 2024 To 2029

Figure 28 Ai In Clinical Trials Market: Drivers, Restraints,

Opportunities, And Challenges

Figure 29 Approval Of Personalized Medicines By Us Fda, 2015–2023

Figure 30 Healthcare Security Breaches Of 500+ Records (2009–2023)

Figure 31 Ai In Clinical Trials Market: Ecosystem Analysis

Figure 32 Ai In Clinical Trials Market: Value Chain Analysis

Figure 33 Ai In Clinical Trials Market: Porter’s Five Forces Analysis

Figure 34 Influence Of Key Stakeholders On Buying Process For

Top Three End Users

Figure 35 Key Buying Criteria For Top Three End Users

Figure 36 Patent Publication Trends In Ai In Clinical Trials Market, 2015–2024

Figure 37 Top Applicants/Owners Of Patents And Number Of Patents Granted, January 2015–november 2024

Figure 38 Ai In Clinical Trials Market: Trends And Disruptions Impacting Customer’s Business

Figure 39 Ai In Clinical Trials Market: Funding And Number Of Deals, 2022–2024

Figure 40 Impact Of Ai/Gen Ai On Ai-based Clinical Trial Solutions

Figure 41 Impact Of Gen Ai On Interconnected And Adjacent Ecosystems

Figure 42 North America: Ai In Clinical Trials Market Snapshot

Figure 43 Asia Pacific: Ai In Clinical Trials Market Snapshot

Figure 44 Revenue Analysis Of Key Players In Ai In Clinical Trials Market, 2019–2023 (Usd Billion)

Figure 45 Market Share Analysis In Ai In Clinical Trials Market (2023)

Figure 46 Ranking Of Key Players In Ai In Clinical Trials Market (2023)

Figure 47 Ai In Clinical Trials Market: Company Evaluation Matrix

(Key Players), 2023

Figure 48 Ai In Clinical Trials Market: Company Footprint

Figure 49 Ai In Clinical Trials Market: Company Evaluation Matrix (Startups/Smes), 2023

Figure 50 Ev/Ebitda Of Key Vendors

Figure 51 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of

Ai In Clinical Trial Key Vendors

Figure 52 Ai In Clinical Trials Market: Brand/Product Comparative Analysis

Figure 53 Iqvia Inc.: Company Snapshot

Figure 54 Dassault Systèmes (Medidata): Company Snapshot

Figure 55 Nvidia Corporation: Company Snapshot

Figure 56 Microsoft: Company Snapshot

Figure 57 Ibm: Company Snapshot

Figure 58 Median Technologies: Company Snapshot